Alexia Monastirioti

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer

Maria A. Papadaki, Anastasios Koutsopoulos, Panormitis G Tsoulfas et al. · Cancers · 2020 · 90 citations · Full text

Medicine, Immunology, Oncology +17

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer

Chara Papadaki, Giannis Stoupis, Leuteris Tsalikis et al. · Oncotarget · 2019 · 47 citations · Full text

Medicine, Cancer Biology, Oncology +16

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

Konstantinos Rounis, Dimitrios Makrakis, Alexandros-Pantelis Tsigkas et al. · Translational Lung Cancer Research · 2021 · 46 citations · Full text

Medicine, Oncology, Pharmacology +16

Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

Konstantinos Rounis, Dimitrios Makrakis, Chara Papadaki et al. · PLoS ONE · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacology +14

Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy

Chara Papadaki, Alexia Monastirioti, Konstantinos Rounis et al. · Cancers · 2020 · 28 citations · Full text

Medicine, Molecular Biology, Oncology +17